GSKR&D Portfolio Intelligence for Billion-Pound Decisions
- Company
- GSK
- Period
- 2022–2023
I led design on an application GSK scientists use to document, track and collaborate through the drug discovery phase, and which gives senior leadership the picture they need to make strategic, data-driven decisions faster.
The application contributed to an estimated £9 billion in cost savings for the company, by streamlining these processes and enabling a more efficient way of working.
This case study is under NDA
Enter the password to read it, or request access and I'll share it.
No password? Request access